Robotic Arm Ushers in New Age of Outpatient Shoulder Surgery

FLORHAM PARK, NJ – April 07, 2026 – A surgeon's plan, once confined to medical imaging and expert estimation, has been translated into robotic reality with sub-millimeter accuracy, marking a significant milestone for American orthopedic care. In a quiet but revolutionary procedure on April 1, Summit Health orthopedic surgeon Dr. Eric Black performed the nation’s first complete robotic-assisted shoulder replacement surgery within a freestanding ambulatory surgery center. The event at the Summit Atlantic Surgery Center (SASC) represents the potent fusion of two of modern medicine's most powerful trends: the precision of robotic surgery and the strategic shift of complex procedures to specialized outpatient facilities.

Using the ROSA® Robotics Platform by Zimmer Biomet, Dr. Black executed both an anatomic and a reverse shoulder replacement, procedures designed to alleviate debilitating conditions like arthritis and severe joint degeneration. This achievement is not merely about a new piece of technology but about a new paradigm of care, promising a more personalized and predictable path to recovery for thousands of patients who suffer from chronic shoulder pain.

“At Summit Health, we are committed to advancing patient care through cutting-edge technology and this milestone marks a significant leap in the field of orthopedic surgery through the personalization and precision of outpatient shoulder replacement procedures,” stated Matthew Garberina, MD, Chief of the Department of Orthopedics at Summit Health. “We applaud Dr. Black for pioneering this innovative approach, setting a new standard for shoulder surgery in the outpatient setting.”

A New Standard of Surgical Precision

The centerpiece of this medical first is the ROSA® Shoulder System, which only received its 510(k) clearance from the U.S. Food and Drug Administration in February 2024. The system is designed to act as a surgeon's high-tech assistant, transforming a detailed preoperative plan into a flawlessly executed procedure.

The process begins days before the surgery, when a patient undergoes a CT scan. This imaging is used to generate a highly detailed, three-dimensional model of the patient's unique shoulder anatomy. Using this virtual model, the surgeon can plan the entire operation, determining the optimal size and positioning of the implant for that specific individual.

“Robotic technology further transforms what is possible for patients undergoing a shoulder replacement because it allows us to personalize and plan the surgery with incredible accuracy,” explained Dr. Black. During the procedure, the robotic arm, guided by the surgeon, uses advanced sensors and real-time feedback to ensure the implant is placed with less than one millimeter of variance from the pre-approved plan. “It’s a huge step forward in enabling the surgeon to accurately execute a customized plan that is unique to each patient. This will likely increase consistency as well as longevity for each patient.”

Historically, surgeons relied on their experience and handheld guides to achieve the correct alignment. While highly effective, this traditional method was subject to the inherent limitations of human feel and vision. “Until now, we didn’t have a way to perfectly reproduce our preoperative plans in real time on the humerus and glenoid,” Dr. Black noted. “Robotic technology brings that vision to life inside the operating room.”

Beyond the Hospital Walls

Just as significant as the technology itself is the setting in which it was deployed. Performing a complete robotic shoulder replacement in a freestanding ambulatory surgery center (ASC) underscores a fundamental shift in how and where surgical care is delivered. For years, joint replacements were exclusively inpatient procedures requiring multi-day hospital stays.

However, extensive research has demonstrated that for carefully selected patients, outpatient shoulder replacement is a safe and effective alternative. Ideal candidates are typically younger than 70, have a BMI under 35, and are free from significant cardiopulmonary conditions. Crucially, they must also have a strong support system at home to assist with post-operative care. This careful selection process ensures that the convenience of a same-day discharge does not compromise patient safety.

The benefits of moving these procedures to ASCs are manifold. These specialized facilities are designed for efficiency, leading to a more streamlined patient experience, reduced infection risk, and greater patient satisfaction. By focusing exclusively on surgical procedures, ASCs can optimize workflows and resources in ways that large, multi-purpose hospitals often cannot.

The Promise of Better Outcomes and the Question of Cost

For patients, the combination of robotic precision and an outpatient setting promises a host of potential benefits. The high degree of accuracy in implant placement may lead to a better fit, improved joint function, and potentially greater longevity of the implant itself. Patients may also experience shorter recovery times and reduced postoperative discomfort compared to traditional approaches.

From a healthcare system perspective, the economic implications are substantial. Studies have consistently shown that procedures performed in ASCs are significantly more cost-effective than those in hospital outpatient departments. For shoulder arthroplasty, the savings can be dramatic, with some analyses showing a charge reduction ranging from $25,000 to over $50,000 per patient. On a macro level, shifting eligible surgeries to ASCs has the potential to save the U.S. healthcare system tens of billions of dollars annually.

However, this cost-saving narrative has a complex flip side for the individual patient. The rise of high-deductible health plans means that even with lower overall procedure costs, patients may face substantial out-of-pocket expenses. While insurers and Medicare save money, the financial burden is increasingly shifting to the consumer, a trend that can impact access to care regardless of the setting.

A New Competitive Frontier in Orthopedics

Summit Health's achievement is not happening in a vacuum. It is a clear signal of a new competitive front in the multi-billion-dollar orthopedic market. Zimmer Biomet's ROSA® system is in direct competition with Stryker's Mako SmartRobotics™ platform, which also recently received FDA approval for shoulder applications. The race is now on for healthcare systems and ASCs across the country to adopt these technologies to attract top surgical talent and a growing population of patients seeking the most advanced care.

This procedure positions Summit Health as a leader in the highly competitive tri-state healthcare market, demonstrating a commitment to investing in technology that directly enhances patient outcomes. The ability to offer cutting-edge robotic surgery in an efficient and convenient outpatient setting is a powerful differentiator. This milestone is less an endpoint and more a starting point, setting a new benchmark that other institutions will undoubtedly rush to meet, ultimately accelerating the adoption of a new standard of care for patients everywhere.